Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

NF-κB Pathway and Its Inhibitors: A Promising Frontier in the Management of Alzheimer’s Disease
Bhagavathi Sundaram Sivamaruthi, Neha R. Raghani, Mehul R. Chorawala, et al.
Biomedicines (2023) Vol. 11, Iss. 9, pp. 2587-2587
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Targeting Metabolic Diseases: The Role of Nutraceuticals in Modulating Oxidative Stress and Inflammation
Aida Dama, Kleva Shpati, Patricia Daliu, et al.
Nutrients (2024) Vol. 16, Iss. 4, pp. 507-507
Open Access | Times Cited: 26
Regulation of the microglial polarization for alleviating neuroinflammation in the pathogenesis and therapeutics of major depressive disorder
Yufei Wang, Cong-Ya Chen, Lan Lei, et al.
Life Sciences (2025) Vol. 362, pp. 123373-123373
Closed Access | Times Cited: 1
Alzheimer’s disease: the role of extrinsic factors in its development, an investigation of the environmental enigma
Swathi Suresh, Ankul Singh S, Rapuru Rushendran, et al.
Frontiers in Neurology (2023) Vol. 14
Open Access | Times Cited: 19
Role of ketogenic diet in neurodegenerative diseases focusing on Alzheimer diseases: The guardian angle
Hayder M. Al‐kuraishy, Majid S. Jabir, Ali K. Albuhadily, et al.
Ageing Research Reviews (2024) Vol. 95, pp. 102233-102233
Closed Access | Times Cited: 10
Eugenol attenuates aluminium-induced neurotoxicity in rats by inhibiting the activation of STAT3 and NF-кB
Chandra Prakāsh, Jyoti Tyagi, Kumari Vandana Singh, et al.
Metabolic Brain Disease (2025) Vol. 40, Iss. 1
Closed Access
Stimulation, regulation, and inflammaging interventions of natural compounds on nuclear factor kappa B (NF-kB) pathway: a comprehensive review
Gowtham Kannan, Benedict Mathews Paul, Parimelazhagan Thangaraj
Inflammopharmacology (2025)
Closed Access
Molecular Mechanisms of Alzheimer’s Disease Induced by Amyloid-β and Tau Phosphorylation Along with RhoA Activity: Perspective of RhoA/Rho-Associated Protein Kinase Inhibitors for Neuronal Therapy
Eun Hee Ahn, Jae‐Bong Park
Cells (2025) Vol. 14, Iss. 2, pp. 89-89
Open Access
Five Key Criteria for Identifying Optimal Therapeutic Targets in Protein‐Mediated Diseases
Mohammed Baqur S. Al‐Shuhaib, Jafar M. B. Al‐Shuhaib
ChemistrySelect (2025) Vol. 10, Iss. 4
Closed Access
Current Advances in the Therapeutic Potential of Scutellarin: Novel Applications, Mechanisms, and Future Challenges.
Great Iruoghene Edo, Alice Njolke Mafe, Patrick Othuke Akpoghelie, et al.
Phytomedicine Plus (2025), pp. 100754-100754
Open Access
Neuroinflammation and Neurodegenerative Diseases: How Much Do We Still Not Know?
Carmela Rita Balistreri, Roberto Monastero
Brain Sciences (2023) Vol. 14, Iss. 1, pp. 19-19
Open Access | Times Cited: 16
Nanoligomers targeting NF-κB and NLRP3 reduce neuroinflammation and improve cognitive function with aging and tauopathy
Devin Wahl, Sydney Risen, Shelby C. Osburn, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 4
Nanoligomers targeting NF-κB and NLRP3 reduce neuroinflammation and improve cognitive function with aging and tauopathy
Devin Wahl, Sydney Risen, Shelby C. Osburn, et al.
Journal of Neuroinflammation (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 4
Effects of Cycloastragenol on Alzheimer's Disease in Rats by Reducing Oxidative Stress, Inflammation, and Apoptosis
Kadi M. Alharbi, Shahad Alshehri, Wasayf A Almarwani, et al.
Current Alzheimer Research (2024) Vol. 21, Iss. 2, pp. 141-154
Closed Access | Times Cited: 3
An insight into the concept of neuroinflammation and neurodegeneration in Alzheimer’s disease: targeting molecular approach Nrf2, NF-κB, and CREB
Shaveta Bhardwaj, Amarjot Kaur Grewal, Shamsher Singh, et al.
Inflammopharmacology (2024) Vol. 32, Iss. 5, pp. 2943-2960
Closed Access | Times Cited: 3
Dietary flavonoids modulate the gut microbiota: A new perspective on improving autism spectrum disorder through the gut-brain axis
H Dai, Yuhan Jiang, Shuxun Liu, et al.
Food Research International (2024) Vol. 186, pp. 114404-114404
Closed Access | Times Cited: 2
Connecting GSK-3β Inhibitory Activity with IKK-β or ROCK-1 Inhibition to Target Tau Aggregation and Neuroinflammation in Alzheimer’s Disease—Discovery, In Vitro and In Cellulo Activity of Thiazole-Based Inhibitors
Izabella Góral, Tomasz Wichur, Emilia Sługocka, et al.
Molecules (2024) Vol. 29, Iss. 11, pp. 2616-2616
Open Access | Times Cited: 2
Breaking Barriers in Alzheimer’s Disease: the Role of Advanced Drug Delivery Systems
Devank Shekho, Ritika Mishra, Raj Kamal, et al.
AAPS PharmSciTech (2024) Vol. 25, Iss. 7
Closed Access | Times Cited: 2
The Impact of NF-κB on Inflammatory and Angiogenic Processes in Age-Related Macular Degeneration
Waleed Hassan Almalki, Salem Salman Almujri
Experimental Eye Research (2024) Vol. 248, pp. 110111-110111
Closed Access | Times Cited: 2
Inhibiting the IRAK4/NF-κB/NLRP3 signaling pathway can reduce pyroptosis in hippocampal neurons and seizure episodes in epilepsy
Ting Zhao, Xuefei Zhang, Xiaoxiao Cui, et al.
Experimental Neurology (2024) Vol. 377, pp. 114794-114794
Closed Access | Times Cited: 1
NF-κB in Alzheimer’s Disease: Friend or Foe? Opposite Functions in Neurons and Glial Cells
Barbara Kaltschmidt, Nele Johanne Czaniera, Wiebke Schulten, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 21, pp. 11353-11353
Open Access | Times Cited: 1
Buyang Huanwu Decoction promotes neurovascular remodeling by modulating astrocyte and microglia polarization in ischemic stroke rats
Mingcong Li, Man-zhong Li, Ziyue Lin, et al.
Journal of Ethnopharmacology (2023) Vol. 323, pp. 117620-117620
Closed Access | Times Cited: 5
An overview of Skp2: a promising new therapeutic target of psoriasis
Yashika Tomar, Moushumi Baidya, Jay Chadokiya, et al.
Expert Opinion on Therapeutic Targets (2024) Vol. 28, Iss. 8, pp. 689-700
Closed Access | Times Cited: 1
Investigating the NF-κB Signaling Pathway in Heart Failure: Exploring Potential Therapeutic Approaches
Mohsen Ghiasi
Heliyon (2024) Vol. 10, Iss. 23, pp. e40812-e40812
Open Access | Times Cited: 1
Prevention of Delayed Cerebral Ischemia after Aneurysmal Subarachnoid Hemorrhage – Expert Consensus and Summary of Existing Evidence
Margaux Miller, Priya Thappa, Hemant Bahagat, et al.
Research Square (Research Square) (2024)
Open Access
A Novel Quinoline Inhibitor of the Canonical NF-κB Transcription Factor Pathway
Panagiotis Ntavaroukas, Karim Michail, Rafaela Tsiakalidou, et al.
Biology (2024) Vol. 13, Iss. 11, pp. 910-910
Open Access
Page 1 - Next Page

Scroll to top